Action Point Financial Planning’s NanoViricides NNVC Stock Holding History

Action Point Financial Planning’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$793	Buy	+575	New	+$788	﹤0.01%	2540

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Action Point Financial Planning's NNVC Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in NanoViricides (NNVC) in Q2 2026: 575 shares worth $793. The stake represents ﹤0.01% of the portfolio and ranks #2540 among its holdings.

48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Action Point Financial Planning held 575 shares of NanoViricides worth $793 as of Q2 2026.
NanoViricides was a new Action Point Financial Planning position in Q2 2026.
NanoViricides made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #2540 holding.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.